Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

$20,014Licensing and royalty revenue1,4171,133Total revenue23,23521,147Expenses:Research and development38,71434,245General and administrative2,9763,010Total operating expenses41,69037,255Loss from operations(18,455)(16,108)Other income (expense):Equity in net loss of Regulus Therapeutics Inc.(976)(856)Investment income600705Interest expense(5,179)(3,415)Gain (loss) on investments, net17(318)Loss before income tax expense$(23,993)$(19,992)Income tax expense(2)(2)Net loss$(23,995)$(19,994)Basic and diluted net loss$(0.24)$(0.20)Shares used in computing basic and diluted net loss per share100,15799,569Isis Pharmaceuticals, Inc.Reconciliation of GAAP to Pro Forma Basis:  Condensed Consolidated Operating Expenses and Loss From Operations (In Thousands)Three months ended,

March 31,20122011(unaudited)As reported operating expenses according to GAAP$41,690$37,255Excluding compensation expense related to equity awards(2,267)(2,732)Pro forma operating expenses$39,423$34,523As reported loss from operations according to GAAP$(18,455)$(16,108)Excluding compensation expense related to equity awards(2,267)(2,732)Pro forma loss from operations$(16,188)$(13,376)Reconciliation of GAAP to Pro Forma Basis
As illustrated in the Selected Financial Information in this press release, pro forma operating expenses and pro forma loss from operations were adjusted from GAAP to exclude compensation expense related to equity awards, which are non-cash.  Isis has regularly reported non-GAAP measures for operating expenses and loss from operations as pro forma results.  These measures are provided as supplementary information and are not a substitute for financial measures calculated in accordance with GAAP.  Isis reports these pro forma results to better enable financial statement users to assess and compare its historical performance and project its future operating results and cash flows.  Further, the presentation of Isis' pro forma results is consi
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
3. Halozyme Reports First Quarter 2012 Financial Results
4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. IRIDEX Reports 2012 First Quarter Results
7. Cambrex Reports First Quarter 2012 Results
8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
11. Neuland Labs Reports Financial Results For Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... CARPINTERIA, Calif. , Sept. 2, 2014 ... assessments and penetration testing services, today released an IT ... industry. "Today,s healthcare CEOs are presiding over ... industry," said Daniel W. Berger , Redspin,s President ... help CEO,s and their Boards of Directors understand why ...
(Date:9/2/2014)... BEIJING , Sept. 2, 2014  Sinovac Biotech Ltd. ... products in China , today announced that ... in September: , Morgan Stanley Global Healthcare Conference, ... September 9 and 10, 2014. , Morgan Stanley Asia ... Hotel on September 11, 2014. , Aegis Healthcare & ...
(Date:9/2/2014)... Sept. 2, 2014  Drug delivery technologies that improve ... part of the entire drug development process. Pharmaceutical ... new vaccine delivery technologies in a bid to ... delivery procedures. New analysis from Frost ... the needle-free delivery sector currently makes up a ...
Breaking Medicine Technology:Sinovac to Participate in Upcoming Investor Conferences 2Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 2Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 MyRounding, the ... care, has been selected from a group of over ... the 2014 PrIME Digital Health Challenge. The competition will ... another, Tuesday, Sept. 9th at the CSU Denver Atrium ... MyRounding is based in Denver, Colo. The cloud-based, SaaS ...
(Date:9/2/2014)... BESLER Consulting, a leading provider of Medicare ... to announce that it has released a special report ... 2015 Hospital Inpatient Prospective Payment System (IPPS) final rule ... Services. , “Hospitals are facing decreased Medicare reimbursements in ... BESLER’s President and Chief Executive Officer. “We are happy ...
(Date:9/2/2014)... September 02, 2014 “Is there an ... question that millions of people ask. Diagnosing and curing ... patients and their families or treatment partners. The diagnostic ... its distinct similarities to other skin conditions such as: ... bites, eczema, varicella and many others. Scabies is ...
(Date:9/2/2014)... 02, 2014 Michigan’s health care landscape ... Act and the Healthy Michigan Plan. Throughout these changes, ... a trusted funding resource for under-served individuals. Federal and ... or underinsured women between the ages of 50 and ... percent of the federal poverty level. , ...
(Date:9/2/2014)... Recently, Os-Monitor.com, an innovative company that provides many kinds ... employee internet monitoring products ( http://www.os-monitor.com ). Furthermore, the ... 10% off, on these useful items. , True ... different kinds of high end monitoring programs on its ... of all sizes. With its high end programs, the ...
Breaking Medicine News(10 mins):Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Useful Employee Internet Monitoring Products Now For Sale At Os-Monitor.com 2
... (sildenafil) can improve exercise capacity and functional ability in ... high pressure in the blood vessels that enter the ... report by Reuters, the findings, which appear in The ... study of 278 patients who were randomly selected to ...
... to stress during early life can lead to an ... adolescence.// It therefore, highlights the need for a counseling ... of growth. ,Several studies have established a ... with an increased risk of developing attachment disorders. These ...
... Death Syndrome (SIDS) has found out that nearly all cases ... a male sex hormone. //The levels are considerably higher in ... who have died suddenly from other causes. ,Researchers ... collected from 169 infants who had died of SIDS and ...
... findings were published by chemists at Harvard University, who ... they trigger could hold the key to oncogenesis,// the ... arises when an oncoprotien, a protein known to cause ... development of cancer, 'We present the hypothesis that an ...
... Research Institute have now found out that heart disease ... the thyroid gland.// Aggressive treatment of hypothyroidism and borderline ... diseases to a significant extent. ,The study has ... can be extrapolated to human beings as well. The ...
... of the National Cancer Institute conducted a meta-analysis of ... and the prevalence and associated mortality from colorectal cancer. ... of the Karolinska Institute in Stockholm, and colleagues. The ... at a 30 percent risk of developing colorectal cancer ...
Cached Medicine News:Health News:Teenage Mental Problems Could Be The Result Of Stress During Early Life 2Health News:Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases 2
The Buckle Apron has a 2" wide belt with a rugged side-release buck. The belt and buckle are adjustable to provide a snug and comfortable fit while still offering .50mm Pb protection....
Setting a new standard in protective apparel. The unique, patented Cool-Tech™ mesh-back design fits the natural contour of the body while reducing the amount of weight carried on the shoulders ...
Apron,special Proceddure...
Crisscross shoulder design facilitates better posture and distributes weight to back and hips for greater comfort. Shoulder pads soften shoulder contact with apron for additional comfort....
Medicine Products: